Evidence map›Paper›PMID 34109145›Full record

ArticleFrontiers in public health2021

Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China.

Xiaodong Sun, Yuekun Tang, Xiaoying Ma, Xiang Guo, Zhuoying Huang, Jia Ren, Jing Qiu, Hongli Jiang, Yihan Lu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaodong SunShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Yuekun TangSchool of Public Health, Fudan University, Shanghai, China.
Xiaoying MaShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Xiang GuoShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Zhuoying HuangShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Jia RenShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Jing QiuShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Hongli JiangSchool of Public Health, Fudan University, Shanghai, China.
Yihan LuSchool of Public Health, Fudan University, Shanghai, China.
Shanghai Municipal Center For Disease Control Prevention · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pneumococcal InfectionsPneumococcal VaccinesAgedChinaCost-Benefit AnalysisHumansQuality-Adjusted Life YearsPneumococcal Vaccinescost-effectivenessPPSV-23Shanghaithe elderlyvaccine

Identifiers

PMID34109145
PMCPMC8181136
OpenAlexW3165320860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.